张倜 - AI Profile | 人才画像

基本信息

浏览量：123

职业迁徙

个人简介

目前担任中国抗癌协会肝癌专业委员会常委，胆道肿瘤专业委员会常委，中国临床肿瘤学会（CSCO）胆道肿瘤专家委员会委员等国内多个学术团体的常委及委员。参与制定国家卫健委《原发性肝癌诊疗规范》，中国《CSCO胆道肿瘤专家共识》及《中国肝癌多学科诊治专家共识》等。

研究兴趣

论文共 166 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Organoid Modeling Identifies USP3-AS1 As a Novel Promoter in Colorectal Cancer Liver Metastasis Through Increasing Glucose-Driven Histone Lactylation

Jia-min Zhou, Wei-xing Dai, Ren-jie Wang, Wei-qi Xu, Zhen Xiang,Yi-xiu Wang,Ti Zhang,Yi-ming Zhao,Lu Wang,An-rong Mao

Acta Pharmacologica Sinicapp.1-15, (2025)

引用0浏览0WOSNATURE引用

Efficacy and Influencing Factors of Immunotherapy Crossover Combined with Targeted Therapy in Advanced Esophageal Cancer Patients Following First-Line Chemotherapy Combined with Immunotherapy Failure

Xiuxiu Li, Fan,Ti Zhang

American journal of cancer researchno. 3 (2025): 1321-1334

引用0浏览0WOS引用

Laparoscopic Versus Open Surgery for Liver Resection: a Multicenter Cohort Study

Yesheng Li,Longrong Wang,Yibin Guo,Jiamin Zhou,Ning Zhang,Xigan He,Yixiu Wang,Weiping Zhu,Miao Wang,Hongxu Zhu,Zhiwen Ding,Yibin Wu,Ti Zhang,Qi Pan,Yun Feng,Zhenhai Lin,Anrong Mao,Yongfa Zhang, Yilin Wang,Bin Zhang, Yangqing Huang,Yiming Zhao,Lu Wang

SCIENTIFIC REPORTSno. 1 (2024)

引用0浏览0WOSNATURE引用

Efficacy and Safety of a Combination of Sintilimab, Bevacizumab Plus Gemcitabine, and Albumin-Bound Paclitaxel for Initially Unresectable Gallbladder Carcinoma: A Prospective, Single-Arm Phase II Study

Miao Wang,Jiamin Zhou,Weiqi Xu, Qi Pan,Anrong Mao,Ning Zhang,Yun Feng,Xigan He, Zhenhai Lin, Longrong Wang,Yongfa Zhang,Hongxu Zhu, Zhiwe Ding,Yixiu Wang, Bingran Yu,Ti Zhang,Lu Wang

Journal of Clinical Oncologyno. 3_suppl (2024): 489-489

引用0浏览0引用

Stereotactic Body Radiation Therapy Combined with Atezolizumab and Bevacizumab for Hepatocellular Carcinoma with Extrahepatic Metastasis: Preliminary Result of a Single-Arm Study

Lu Wang,Ti Zhang,Zhenhai Lin,Jiamin Zhou,Juefeng Wan,Qi Pan,Yiming Zhao,Weiping Zhu,Anrong Mao,Ning Zhang,Longrong Wang

Journal of Clinical Oncology（2024）

引用0浏览0引用

GPR37 Promotes Colorectal Cancer Against Ferroptosis by Reprogramming Lipid Metabolism Via P38-Scd1 Axis

Jiamin Zhou,Xigan He,Weixing Dai,Qingguo Li, Zhen Xiang,Yixiu Wang,Ti Zhang,Weiqi Xu,Lu Wang,Anrong Mao

Apoptosis（2024）

引用0浏览0WOS引用

GPR37 Promotes Colorectal Cancer Liver Metastases by Enhancing the Glycolysis and Histone Lactylation Via Hippo Pathway

Jiamin Zhou,Weiqi Xu,Yibin Wu,Miao Wang,Ning Zhang,Longrong Wang,Yun Feng,Ti Zhang,Lu Wang,Anrong Mao

ONCOGENEno. 45 (2023): 3319-3330

引用18浏览0WOSNATURE引用

Lenvatinib Plus Sintilimab with or Without Transarterial Chemoembolization for Intermediate or Advanced Stage Hepatocellular Carcinoma: a Propensity Score-Matching Cohort Study

Mengran Lang,Leijuan Gan,Shaohua Ren,Ruyu Han,Xiaochen Ma,Guangtao Li,Huikai Li,Ti Zhang,Qiang Wu,Yunlong Cui,Wei Zhang,Feng Fang,Qiang Li,Wei Lu,Tianqiang Song

AMERICAN JOURNAL OF CANCER RESEARCHno. 6 (2023): 2540-+

引用0浏览0WOS引用

A Gene Mutation-Based Risk Model for Prognostic Prediction in Liver Metastases

Bingran Yu,Ning Zhang,Yun Feng,Weiqi Xu,Ti Zhang,Lu Wang

BMC Genomicsno. 1 (2023)

引用0浏览0WOS引用

Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibodies with Hepatic Arterial Infusion Chemotherapy or Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma

Bingran Yu,Ning Zhang,Yun Feng,Yongfa Zhang,Ti Zhang,Lu Wang

JOURNAL OF HEPATOCELLULAR CARCINOMA（2023）

引用2浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn

Ti Zhang(张倜)

主任医师

论文共 166 篇作者统计合作学者相似作者